Physidia SA, headquartered in France, is a leading player in the medical technology industry, specialising in innovative solutions for the healthcare sector. Founded in 2015, the company has rapidly established itself as a pioneer in the development of advanced medical imaging and diagnostic tools, particularly in the fields of radiology and oncology. With a strong presence across Europe and expanding operations in key international markets, Physidia SA is renowned for its unique software solutions that enhance the accuracy and efficiency of medical imaging processes. The company’s flagship products, which integrate cutting-edge artificial intelligence, set new standards in patient care and diagnostic precision. Recognised for its commitment to innovation, Physidia SA has achieved significant milestones, including partnerships with leading healthcare institutions and accolades for its contributions to medical technology. As a trusted name in the industry, Physidia SA continues to shape the future of healthcare with its groundbreaking advancements.
How does Physidia SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Physidia SA's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Physidia SA, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, it appears that Physidia SA has not yet established formal commitments to reduce its carbon footprint or engage in climate initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate change impacts. However, without specific data or commitments from Physidia SA, it is unclear how the company aligns with these industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Physidia SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

